Analytical profile of trazodone
Baiocchi, L.; Chiari, A.; Frigerio, A.; Ridolfi, P.
Arzneimittel-Forschung 23(3): 400-406
1973
ISSN/ISBN: 0004-4172 PMID: 4740125 Document Number: 66571
Document emailed within 1 workday
Related Documents
Seccia, S. 1994: Analytical profile of zolpidem Bollettino della Societa Italiana di Biologia Sperimentale 70(5-6): 151-157Crimella, T.; Orlandi, R.; Bocchiola, G.; Anders, U.; Stradi, R. 1994: Analytical and chemical profile of pidotimod Arzneimittel-Forschung 44(12a): 1405-1410
Malík, I. 2011: Analytical profile of 1-[3-(3-propoxyphenylcarbamoyloxy)-2-hydroxypropyl]-4-(3-trifluoromethylphenyl)piperazinium chloride Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 60(6): 283-289
Colombo, N.; Depaoli, A.; Gobetti, M.; Saorin, M.G. 1994: Analytical-physical profile of the novel macrolide antibiotic flurithromycin ethylsuccinate Arzneimittel-Forschung 44(7): 850-855
Guechot, C.; Bertrand, A.; Cramaille, P.; Teulon, J.M. 1988: Analytical profile of the new diuretic beta-blocking agent tienoxolol hydrochloride Arzneimittel-Forschung 38(5): 655-660
Picco, S.; Bonaldi, A.; Frigerio, A.; Danieli, B.; Almirante, L. 1974: Metabolic fate of Zolimidine. II. Analytical profile, tissue levels and urinary excretion in animals and in man Il Farmaco; Edizione Scientifica 29(11): 848-860
Hughes, S; Wilkinson, R; Humphreys, D; Macmillan, T; Rae, I D. 2001: Profile 1 - The Global Compact: Promoting Corporate Responsibility? Profile 2 - The Creation of the United Nations Forum on Forests Profile 3 - The rBST Ban - A Taste of What's to Come for GM Foods? Profile 4 - Managing Waste Organochlorine Chemicals in Australia Environmental Politics 10(1): 155-177
Jacobsz, M.; Dednam, M. 2007: Pre-analytical, analytical and postanalytical considerations in glucose point-of-care testing South African Medical Journal 97(9): 805
Ortiz, M.C.; Sarabia, L.A.; Sánchez, M.S. 2023: The inversion of multiresponse partial least squares models, a useful tool to improve analytical methods in the framework of analytical quality by design Analytica Chimica Acta 1276: 341620
Tingle, D. 1986: Trazodone in dementia Journal of Clinical Psychiatry 47(9): 482
Vinar, O.; Topiar, A.; Muronová, J. 1979: Trazodone in depressions Activitas Nervosa Superior 21(3): 148-150
Johnson, B.A. 1985: Trazodone toxicity British Journal of Hospital Medicine 33(5): 298
Peabody, C.A. 1987: Trazodone withdrawal and formication Journal of Clinical Psychiatry 48(9): 385
Gershon, S.; Yeragani, V.K.; Aleem, A. 1986: Tolerance and pharmacovigilance of trazodone L'Encephale 12(Special Issue): 249-257
Rurak, A.; Melzacka, M.; Danek, L. 1981: Pharmacokinetics of trazodone after different routes of administration Polish Journal of Pharmacology and Pharmacy 33(3): 341-348
Roccatagliata, G.; Gandolfo, C.; Cammarata, S.; De Martini, I.; Arcuri, T. 1979: Treatment of depression in the menopause with trazodone La Clinica Terapeutica 91(1): 67-72
Baiocchi, L.; Frigerio, A.; Giannangeli, M.; Palazzo, G. 1974: Basic metabolites of trazodone in humans Arzneimittel-Forschung 24(10): 1699-1706
Gershon, S. 1990: Insights in the use of trazodone in depressed patients Journal of Clinical Psychiatry 51 Suppl: 4-5
Darko, W.; Guharoy, R.; Rose, F.; Lehman, D.; Pappas, V. 2001: Myoclonus secondary to the concurrent use of trazodone and fluoxetine Veterinary and Human Toxicology 43(4): 214-215
Gałecki, P.; Florkowski, A. 2010: Effectiveness of trazodone in the treatment of sexual dysfunctions Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 29(169): 66-69